Skip to main content

FATE Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Fate Therapeutics Inc. News

This CRISPR Stock Plunged On Cell Therapy's Looming Question

A certain type of cell therapy is easier to manufacture, but may lead to worse long-term outcomes for patients.

Fate Therapeutics Stock Falls on Trial Data for Lymphoma Treatment

Fate Therapeutics falls as a trial of its B-cell lymphoma treatment produces mixed results.

Why 2018 will be better for biotech deals than 2017

Analysts see a year of robust deal action ahead due in part to clarity from a tax standpoint.

Immunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism--ICYMI

Here's what you need to know now for Monday, Jan. 22.

Immunotherapy stocks power higher on Celgene-Juno deal

Shares of immunotherapy companies including Ziopharm Oncology and Fate Therapeutics rose early on Monday on the heels of Juno Therapeutics' announced sale to Celgene.

Breaking News

GameStop Declares 4-for-1 Stock Split

GameStop's board declared a 4-for-1 stock split.

Elon Musk Has Reportedly Had Two More Kids

Tesla CEO fathered twins with executive at Neuralink, according to report.

Alphabet Stock Is Setting Up for a Trade Ahead of Stock Split

Alphabet stock has an interesting setup before the tech giant splits the shares. Here's the trade to know.

Microsoft Supports Abortion Access But Is Silent on Data Privacy

The software giant hasn't said it will protect user data in wake of Supreme Court ruling overturning Roe.